{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:52:23Z","timestamp":1790859143653,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003172","name":"Henan University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003172","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bioorg.2026.109560","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:09:22Z","timestamp":1769270962000},"page":"109560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Structure-activity relationship and anticancer mechanism of febuxostat-1,2,3-triazole hybrids inducing DNA damage and apoptosis"],"prefix":"10.1016","volume":"171","author":[{"given":"Xixi","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109560_bb0005","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.4254\/wjh.v15.i12.1258","article-title":"Multifunctional roles of inflammation and its causative factors in primary liver cancer:A literature review","volume":"15","author":"Chen","year":"2023","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.bioorg.2026.109560_bb0010","doi-asserted-by":"crossref","first-page":"16172","DOI":"10.1200\/JCO.2024.42.16_suppl.e16174","article-title":"TACE-HAIC combined with donafenib and immunotherapy for hepatocellular carcinoma (HCC) with portal vein tumour thrombus (PVTT): a retrospective analysis","volume":"42","author":"Yin","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.109560_bb0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12072-023-10618-6","article-title":"Interferon therapy improves survival in patients with hepatitis B virus-related hepatocellular carcinoma after curative surgery: a meta-analysis","volume":"18","author":"Luo","year":"2024","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.bioorg.2026.109560_bb0020","article-title":"Cluster analysis of hepatocellular carcinoma prognosis using preoperative alpha-fetoprotein and des-gamma-carboxy prothrombin levels: a multi-institutional study","volume":"29","author":"Saegusa","year":"2025","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.bioorg.2026.109560_bb0025","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/cancers17030392","article-title":"Hepatic Iron overload and hepatocellular carcinoma: new insights into pathophysiological mechanisms and therapeutic approaches","volume":"17","author":"Chatzikalil","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2026.109560_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29081898","article-title":"Development of glycosylation-modified (D)PPA-1 compounds as innovative PD-1\/PD-L1 blockers: design, synthesis, and biological evaluation","volume":"29","author":"Deng","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109560_bb0035","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/ijms26020510","article-title":"Expression of ABCB1, ABCC1, and LRP in mesenchymal stem cells from human amniotic fluid and bone marrow in culture-effects of in vitro osteogenic and Adipogenic differentiation","volume":"26","author":"Romao","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.109560_bb0040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1515\/biol-2021-0017","article-title":"ABCB1polymorphism in clopidogrel-treated Montenegrin patients","volume":"16","author":"Mugosa","year":"2021","journal-title":"Open Life Sci."},{"key":"10.1016\/j.bioorg.2026.109560_bb0045","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.7314\/APJCP.2014.15.16.6849","article-title":"Establishment and partial characterization of an Epirubicin-resistant gastric Cancer cell line with upregulated ABCB1","volume":"15","author":"Felipe","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.bioorg.2026.109560_bb0050","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/mco2.106","article-title":"Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR\/Cas9 system in SW620\/Ad300 colorectal cancer cells","volume":"2","author":"Lei","year":"2021","journal-title":"MedComm"},{"key":"10.1016\/j.bioorg.2026.109560_bb0055","doi-asserted-by":"crossref","first-page":"13972","DOI":"10.3390\/ijms241813972","article-title":"Furmonertinib, a third-generation EGFR tyrosine kinase inhibitor, overcomes multidrug resistance through inhibiting ABCB1 and ABCG2 in Cancer cells","volume":"24","author":"Wu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.109560_bb0060","first-page":"1339","article-title":"DNA damage in dihydroartemisinin-resistant Molt-4 cells","volume":"35","author":"Park","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bioorg.2026.109560_bb0065","doi-asserted-by":"crossref","first-page":"831","DOI":"10.32604\/or.2024.031006","article-title":"Deciphering resistancemechanisms and novel strategies to overcome drug resistance in ovarian cancer:a comprehensive review","volume":"32","author":"Alemzadeh","year":"2024","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bioorg.2026.109560_bb0070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1586\/era.11.201","article-title":"Molecular mechanisms of cisplatin resistance in bladder cancer","volume":"12","author":"Drayton","year":"2012","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.bioorg.2026.109560_bb0100","doi-asserted-by":"crossref","first-page":"8784","DOI":"10.1021\/acs.jmedchem.9b00942","article-title":"Inhibition mechanisms of indoleamine 2,3-dioxygenase 1 (IDO1)","volume":"62","author":"Rohrig","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109560_bb0075","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1021\/ml900022q","article-title":"NH-1,2,3-triazole inhibitors of the VIM-2 Metallo-\u03b2-lactamase","volume":"1","author":"Weide","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109560_bb0080","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1021\/acs.jmedchem.4c00652","article-title":"Triazoles in medicinal chemistry: physicochemical properties, Bioisosterism, and application","volume":"67","author":"Guan","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109560_bb0085","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1039\/C4MD00031E","article-title":"Synthesis and biological evaluation of coumarin-1,2,3-triazole-dithiocarbamate hybrids as potent LSD1 inhibitors","volume":"5","author":"Ye","year":"2014","journal-title":"MedChemComm"},{"key":"10.1016\/j.bioorg.2026.109560_bb0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejmech.2012.12.046","article-title":"Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents","volume":"62","author":"Duan","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109560_bb0105","doi-asserted-by":"crossref","first-page":"1265289","DOI":"10.3389\/fphar.2023.1265289","article-title":"Design and synthesis of cabotegravir derivatives bearing 1,2,3-triazole and evaluation of anti-liver cancer activity","volume":"14","author":"Xie","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109560_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106926","article-title":"Discovery of dolutegravir-1,2,3-triazole derivatives against prostate cancer via inducing DNA damage","volume":"141","author":"Zhou","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109560_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107437","article-title":"Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: design, synthesis, and molecular docking study","volume":"148","author":"El Hamaky","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109560_bb0115","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1080\/14756366.2021.2021898","article-title":"Synthesis, computational study and biological evaluation of 9-acridinyl and 1-coumarinyl-1,2,3-triazole-4-yl derivatives as topoisomerase II inhibitors","volume":"37","author":"Abdel-Hafez","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109560_bb0120","article-title":"Synthesis of fused 1,2,3-triazoles of clioquinol via sequential CuAAC and C H arylation; in vitro anticancer activity, in silico DNA topoisomerase II inhibitory activity and ADMET","volume":"1250","author":"Srinivas","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109560_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118434","article-title":"Chemical induction of ferroptosis through GPX4 inhibition: rational design of triazole-benzoxazine hybrids for melanoma therapy","volume":"303","author":"Feng","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109560_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202400275","article-title":"Unveiling of indanone-benzimidazole hybrids as anti-alzheimer' s agents: computational and experimental studies","volume":"9","author":"Kushwaha","year":"2024","journal-title":"Chemistryselect"},{"key":"10.1016\/j.bioorg.2026.109560_bb0135","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/s41440-023-01198-x","article-title":"Febuxostat and renal outcomes: post-hoc analysis of a randomized trial","volume":"46","author":"Kohagura","year":"2023","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.bioorg.2026.109560_bb0140","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13757","article-title":"Cardiovascular safety of febuxostat versus allopurinol among the Asian patients with or without gout: a systematic review and meta-analysis","volume":"17","author":"Deng","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.bioorg.2026.109560_bb0145","doi-asserted-by":"crossref","first-page":"2332956","DOI":"10.1080\/07853890.2024.2332956","article-title":"Febuxostat provides renoprotection in patients with hyperuricemia or gout: a systematic review and meta-analysis of randomized controlled trials","volume":"56","author":"Yang","year":"2024","journal-title":"Ann. Med."},{"key":"10.1016\/j.bioorg.2026.109560_bb0150","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","article-title":"Cardiovascular safety of febuxostat or allopurinol in patients with gout","volume":"378","author":"White","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.109560_bb0155","doi-asserted-by":"crossref","DOI":"10.1039\/C6RA24651F","article-title":"Synthesis and bioevaluation of 2-phenyl-5-methyl-2H-1,2,3-triazole-4-carboxylic acid\/carbohydrazide derivatives as potent xanthine oxidase inhibitors","volume":"6","author":"Shi","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.109560_bb0160","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1093\/nar\/gkt828","article-title":"On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs","volume":"41","author":"Wu","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.109560_bb0165","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Computer- Aided Mol. Design"},{"key":"10.1016\/j.bioorg.2026.109560_bb0170","unstructured":"Schr\u00f6dinger LJSINY, NY, USA (2021) Schr\u00f6dinger Release 2022\u20133: LigPrep."},{"key":"10.1016\/j.bioorg.2026.109560_bb0175","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109560_bb0180","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/prot.23106","article-title":"The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling","volume":"79","author":"Li","year":"2011","journal-title":"Proteins"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826000969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826000969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:11:28Z","timestamp":1770973888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826000969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":36,"alternative-id":["S0045206826000969"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109560","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationship and anticancer mechanism of febuxostat-1,2,3-triazole hybrids inducing DNA damage and apoptosis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109560","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109560"}}